Marie Kroemer

6PUBLICATIONS
39CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Life cycle assessment and industrial ecologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 20, 2025
Targeting SALL4 with an HLA Class I-Restricted TCR for Cancer Immunotherapy.

Myriam Ben Khelil, Maxime Fredon, Nawfel Adib

|Sep 03, 2025
Excess volume addition method improves human resource efficiency and environmental sustainability of cytotoxic drug preparations.

Marie Kroemer, Guillaume Galy, Severine Tarun-Coquoz

|Feb 24, 2025
Carbon footprint of a chemotherapy production unit within a hospital pharmacy: Time for green pharmacy.

Manon Chabane, Christine Fagnoni-Legat, Camille Hosotte

|Jan 31, 2025
Predictive biomarkers and specific immune responses of COVID-19 mRNA vaccine in patients with cancer: prospective results from the CACOV-VAC trial.

Laurie Spehner, Emeline Orillard, Antoine Falcoz

|Sep 07, 2022
Safety, Immunogenicity, and 1-Year Efficacy of Universal Cancer Peptide-Based Vaccine in Patients With Refractory Advanced Non-Small-Cell Lung Cancer: A Phase Ib/Phase IIa De-Escalation Study.

Olivier Adotévi, Dewi Vernerey, Pascale Jacoulet

|Nov 24, 2020
Investigation of the prognostic value of CD4 T cell subsets expanded from tumor-infiltrating lymphocytes of colorectal cancer liver metastases.

Marie Kroemer, Celia Turco, Laurie Spehner

Pageof 1

Frequent Collaborators

4 joint publications

Olivier Adotévi

2 joint publications

Laurent Carrez

2 joint publications

Romain Loyon

1 joint publications

Caroline Laheurte